封面
市场调查报告书
商品编码
1516096

骨空隙填充剂市场 - 按材料类型、形式、应用、最终用途 - 全球预测

Bone Void Fillers Market - By Material Type, Form, Application, End-use - Global Forecast

出版日期: | 出版商: Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于骨科疾病和骨骼相关疾病(如骨质疏鬆症、关节炎和骨折)盛行率不断上升,骨空隙填充剂市场规模预计从 2024 年到 2032 年复合年增长率将达到创纪录的 6.8%。根据世界卫生组织的数据,全世界约有 3.5 亿人患有某种关节炎。容易发生骨质流失和骨折的老年人数量不断增加,需要有效的骨科植入物来促进癒合。医疗技术的进步有助于开发更复杂的生物相容性材料,以增强骨骼再生和整合。

由于创伤和运动伤害而增加的外科手术也将推动市场成长。随着人们参与体育运动和高强度运动的增多,需要手术干预并进行骨填充的骨科病变的发生率也会激增。新兴国家为扩大先进骨科手术的可用性而不断增加的政府支持政策和不断增加的医疗保健支出将有利于产品需求。骨空隙填充剂产业分为材料类型、形式、应用、最终用途和区域。

根据材料类型,由于其卓越的生物相容性、可吸收性和临床环境中的易用性,硫酸钙细分市场的市场份额将在 2024 年至 2032 年间录得可观的增长率。硫酸钙是新骨生长的良好支架,可在自然骨再生时提供暂时性回缩支撑,从而减少第二次手术去除填充物的需要。涵盖骨科、牙科和脸部手术的多功能性优势将推动产品需求。

颗粒形式的骨空隙填充剂产业预计在 2024 年至 2032 年期间将显着增长,原因是其多功能性、易于使用以及促进骨再生的有效性。颗粒提供了可客製化的解决方案,用于填充不同形状和尺寸的骨缺损,使其成为各种骨科和牙科治疗的理想选择。这些颗粒具有允许血管渗透并促进成骨细胞迁移的多孔结构,对于新骨的形成至关重要。

到 2032 年,亚太地区骨空隙填充剂产业规模将大幅成长,原因是医疗基础设施和支出不断扩大,以及人口老化导致骨相关疾病盛行率上升。中国和印度的快速城市化和工业化导致受伤率上升,进一步推动了对有效骨科修復解决方案的需求。不断增长的医疗旅游业,特别是在泰国和马来西亚,以实惠的成本提供先进的骨科服务并吸引国际患者,将促进该地区市场的成长。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 骨骼疾病和损伤的发生率增加
      • 老年人口增加
      • 手术技术的进步
      • 日益增长的骨科手术
    • 产业陷阱与挑战
      • 与骨骼疾病相关的高成本
      • 严格的监管场景
  • 成长潜力分析
  • 技术景观
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场估计与预测:按材料类型,2021 - 2032 年

  • 主要趋势
  • 去矿骨基质
  • 硫酸钙
  • 胶原蛋白基质
  • 磷酸三钙
  • 其他材料类型

第 6 章:市场估计与预测:按形式,2021 - 2032

  • 主要趋势
  • 凝胶
  • 颗粒剂
  • 贴上
  • 油灰
  • 其他形式

第 7 章:市场估计与预测:按应用分类,2021 - 2032

  • 主要趋势
  • 脊椎融合
  • 骨折
  • 关节重建
  • 其他应用

第 8 章:市场估计与预测:按最终用途,2021 - 2032 年

  • 主要趋势
  • 医院
  • 骨科诊所
  • 门诊手术中心
  • 其他最终用户

第 9 章:市场估计与预测:按地区划分,2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 10 章:公司简介

  • Abyrx, Inc.
  • Baxter International Inc.
  • Bioventus Inc.
  • BONESUPPORT HOLDING AB
  • Johnson & Johnson
  • Medline Industries, Inc.
  • Medtronic plc
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings, Inc.
简介目录
Product Code: 8861

Bone void fillers market size is set to record 6.8% CAGR from 2024 to 2032, driven by the rising prevalence of orthopedic conditions and bone-related diseases, such as osteoporosis, arthritis, and bone fractures. As per WHO, around 350 million people worldwide have some kind of arthritis. The rise in number of older individuals susceptible to bone mass loss and fractures is necessitating effective orthopedic implants to facilitate healing. Advancements in medical technology are helping in developing more sophisticated biologically compatible materials to enhance bone regeneration and integration.

Rising surgical procedures due to trauma and sports injuries will also drive the market growth. As participation in sports and high-impact exercise is increasing, the incidence of orthopedic lesions requiring surgical intervention followed by bone filling will also surge. Rising supportive government policies and the increasing healthcare expenditures in emerging countries for expanding the availability of advanced orthopedic procedures will favor the product demand. The bone void fillers industry is segmented into material type, form, application, end-use, and region.

Based on material type, the market share from the calcium sulfate segment will record a decent growth rate between 2024 and 2032 due to its exceptional biocompatibility, resorbability, and ease of use in clinical settings. Calcium sulfate acts as a good scaffold for new bone growth for providing temporary retraction support when natural bone regenerate, reducing the need for a second operation to remove the filling on. Benefits of versatility, covering orthopedic, dental, and facial surgery will drive the product demand.

Bone void fillers industry from the granules form segment is anticipated to witness significant growth through 2024-2032 driven by its versatility, ease of application, and effectiveness in promoting bone regeneration. Granules offer a customizable solution for filling bone defects of different shapes and sizes, making them ideal for a wide range of orthopedic and dental treatments. With porous structure that allows blood vessels to permeate and promote the migration of osteoblasts, these granules have grown critical for new bone formation.

Asia Pacific bone void fillers industry size will record substantial growth through 2032, attributed to expanding healthcare infrastructure and expenditure along with the rising prevalence of bone-related ailments due to aging population. Rapid urbanization and industrialization in China and India have led to increased injury rates, further driving the demand for effective orthopedic restorative solutions. The growing medical tourism industry, especially in Thailand and Malaysia for offering advanced orthopedic services at affordable costs and attracting international patients will add to the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of bone disorders and injuries
      • 3.2.1.2 Rise in geriatric population
      • 3.2.1.3 Advancements in surgical techniques
      • 3.2.1.4 Growing orthopedic surgeries
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with bone disorders
      • 3.2.2.2 Stringent regulatory scenario
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Material Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Demineralized bone matrix
  • 5.3 Calcium sulfate
  • 5.4 Collagen matrix
  • 5.5 Tricalcium phosphate
  • 5.6 Other material types

Chapter 6 Market Estimates and Forecast, By Form, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Gel
  • 6.3 Granules
  • 6.4 Paste
  • 6.5 Putty
  • 6.6 Other forms

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Spine fusion
  • 7.3 Bone fracture
  • 7.4 Joint reconstruction
  • 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Orthopedic clinics
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Abyrx, Inc.
  • 10.2 Baxter International Inc.
  • 10.3 Bioventus Inc.
  • 10.4 BONESUPPORT HOLDING AB
  • 10.5 Johnson & Johnson
  • 10.6 Medline Industries, Inc.
  • 10.7 Medtronic plc
  • 10.8 Stryker Corporation
  • 10.9 Wright Medical Group N.V.
  • 10.10 Zimmer Biomet Holdings, Inc.